Physician profile
Grant Gibb
NPI 1225416951
$862.94
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.77 · 2023: $268 · 2024: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $695 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $695.17 |
| Education | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $237.84 | 2023-2024 | |
| Alexion Pharmaceuticals, INC. | $150.00 | 2024 | Ultomiris |
| Ucb, INC. | $76.58 | 2023-2024 | Briviact, Rystiggo |
| Pfizer INC. | $34.83 | 2023-2024 | |
| Kyowa Kirin, INC. | $32.29 | 2023-2024 | Nourianz |
| Acadia Pharmaceuticals INC | $32.00 | 2024 | Nuplazid |
| Genentech USA, INC. | $30.98 | 2023 | Ocrevus, Enspryng |
| Merz Pharmaceuticals, LLC | $29.46 | 2024 | Xeomin |
| Argenx US, INC. | $25.80 | 2024 | Vyvgart Hytrulo |
| Amgen INC. | $24.76 | 2023 | Aimovig |
| Amneal Pharmaceuticals LLC | $23.85 | 2024 | Rytary |
| Eisai INC. | $23.37 | 2024 | |
| Abbott Laboratories | $23.18 | 2023 | Jot Dx |
| Lilly USA, LLC | $21.75 | 2024 | Emgality, Reyvow |
| Neurocrine Biosciences, INC. | $20.30 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $19.66 | 2024 | |
| Allergan, INC. | $17.77 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.35 | 2024 | Austedo Xr |
| Celgene Corporation | $13.09 | 2023 | Zeposia |
| Sumitomo Pharma America, INC. | $11.08 | 2023 | Aptiom |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Gibb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.